Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gyre Therapeutics, Inc. - Common Stock (NQ: GYRE ) 12.15 -0.36 (-2.88%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Gyre Therapeutics, Inc. - Common Stock Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia July 02, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology June 18, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension May 30, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes May 28, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update March 26, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum March 21, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting November 13, 2023 From Gyre Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.